<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CLONAZEPAM</span><br/>(kloe-na'zi-pam)<br/><span class="topboxtradename">Klonopin, </span><span class="topboxtradename">Klonopin Wafers, </span><span class="topboxtradename">Rivotril <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anticonvulsant</span>; <span class="classification">benzodiazepine</span><br/><b>Prototype: </b>Diazepam<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.5 mg, 1 mg, 2 mg tablets; 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, and 2 mg orally disintegrating wafers</p>
<h1><a name="action">Actions</a></h1>
<p>
<small>BENZODIAZEPINE</small> derivative with strong anticonvulsant activity and several other pharmacologic properties characteristic of the drug class.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Suppresses spike and wave discharge in absence seizures (petit mal) and decreases amplitude, frequency, duration, and spread
         of discharge in minor motor seizures.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Alone or with other drugs in absence, myoclonic, and akinetic seizures, Lennox-Gastaut syndrome, absence seizures refractory
         to succinimides or valproic acid, and for infantile spasms and restless legs.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Panic disorder, complex partial seizure pattern, and generalized tonic-clonic convulsions.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to benzodiazepines; liver disease; acute narrow-angle glaucoma; pregnancy (category C), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Renal disease; COPD; drug-controlled open-angle glaucoma; addiction-prone individuals; children (because of unknown consequences
         of long-term use on growth and development); patient with mixed seizure disorders.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Seizures</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1.5 mg/d in 3 divided doses, increased by 0.51 mg q3d until seizures are controlled or until intolerable adverse effects
               (max recommended dose: 20 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i> 0.010.03 mg/kg/d (not to exceed 0.05 mg/kg/d) in 3 divided doses; may increase by 0.250.5 mg q3d until seizures
               are controlled or until intolerable adverse effects (max recommended dose: 0.2 mg/kg/d)<br/><br/><span class="indicationtitle">Panic Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12 mg/d in divided doses (max: 4 mg/d)<br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give largest dose at bedtime if daily dose cannot be equally divided.</li>
<li>Place wafer form on tongue to dissolve.</li>
<li>If clonazepam is to replace a different anticonvulsant, verify whether or not the prior drug should be gradually tapered.</li>
<li>Store in tightly closed container protected from light at 15°30° C (59°86° F) unless otherwise
            specified.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> CV:</span> Palpitations. <span class="typehead">GI:</span> Dry mouth, sore gums, anorexia, coated tongue, increased salivation, increased appetite, nausea, constipation, diarrhea. <span class="typehead">Hematologic:</span> Anemia, leukopenia, thrombocytopenia, eosinophilia. <span class="typehead"> CNS:</span>
<span class="speceff-common">Drowsiness, sedation, ataxia,</span> insomnia, aphonia, choreiform movements, <span class="speceff-life">coma</span>, dysarthria, "glassy-eyed" appearance, headache, hemiparesis, hypotonia, slurred speech, tremor, vertigo, confusion,
      depression, hallucinations, aggressive behavior problems, hysteria, suicide attempt. <span class="typehead">Respiratory:</span> Chest congestion, <span class="speceff-life">respiratory depression</span>, rhinorrhea, dyspnea, hypersecretion in upper respiratory passages. <span class="typehead">Skin:</span> Hirsutism, hair loss, skin rash, ankle and facial edema. <span class="typehead">Special Senses:</span> Diplopia, nystagmus, abnormal eye movements. <span class="typehead">Urogenital:</span> Increased libido, dysuria, enuresis, nocturia, urinary retention. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Clonazepam causes transient elevations of <span class="alt">serum transaminase</span> and <span class="alt">alkaline phosphatase.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> and other <span class="classification">cns depressants</span> increase sedation and CNS depression; may increase <b>phenytoin</b> levels. <span class="typehead">Herbal:</span>
<b>Kava-kava,</b>
<b>valerian</b> may potentiate sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 60 min. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> Up to 12 h in adults; 68 h in children. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine primarily as metabolites. <span class="typehead">Half-Life:</span> 1840 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor I&amp;O ratio and patterns: Excess accumulation of metabolites due to impaired excretion leads to toxicity.</li>
<li>Assess carefully for signs of overdosage or drug interaction, i.e., increased depressant adverse effects, if multiple anticonvulsants
            are being given.
         </li>
<li>Lab tests: Periodic liver function tests, platelet counts, blood counts, and renal function tests.</li>
<li>Watch patient to see that he or she does not cheek the tablet. Both psychological and physical dependence may occur in the
            patient on long-term, high-dose therapy. Limit availability of large amounts of drug in the addiction-prone individual.
         </li>
<li>Monitor for S&amp;S of overdose, including somnolence, confusion, irritability, sweating, muscle and abdominal cramps, diminished
            reflexes, coma.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report loss of seizure control promptly. Anticonvulsant activity is often lost after 3 mo of therapy; dosage adjustment may
            reestablish efficacy.
         </li>
<li>Do not abruptly discontinue this drug. Abrupt withdrawal can precipitate seizures. Other withdrawal symptoms include convulsion,
            tremor, abdominal and muscle cramps, vomiting, sweating.
         </li>
<li>Take drug as prescribed and do not alter dosing regimen without consulting physician.</li>
<li>Do not self-medicate with OTC drugs before consulting the physician.</li>
<li>Do not drive a car or engage in other activities requiring mental alertness and physical coordination until reaction to the
            drug is known. Drowsiness occurs in approximately 50% of patients.
         </li>
<li>Carry identification (e.g., Medic Alert) bearing information about medication in use and the diagnosis.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>